Overview
Mu-hua Cheng practices practicing medicine in Guangzhou, China.
Their clinical expertise encompasses Kikuchi Disease, Splenomegaly, Lymphadenitis, and Necrosis.
They are actively involved in clinical research, co-authoring 21 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mu-hua H. Cheng
Is Mu-hua H. Cheng a top-rated expert for Kikuchi Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Mu-hua H. Cheng is classified as an Experienced expert for Kikuchi Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mu-hua H. Cheng participate in research or clinical trials?
Yes. Mu-hua H. Cheng has published 21 articles and abstracts on conditions like Kikuchi Disease. You can view a list of Mu-hua H. Cheng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Kikuchi DiseaseCheng isExperienced. Learn about Kikuchi Disease.
- LymphadenitisCheng isExperienced. Learn about Lymphadenitis.
- NecrosisCheng isExperienced. Learn about Necrosis.
- Obsessive-Compulsive Disorder (OCD)
- SplenomegalyCheng isExperienced. Learn about Splenomegaly.